Author(s): Srinivasarao Pakalapati, Paul Douglas, Chidananda Swamy Rumalla, Muralidharan Kaliyaperumal
DOI: 10.52711/0974-360X.2022.00433
Views:
53
(pdf),
3035
(html)
Access:
Open Access
Cite: Srinivasarao Pakalapati, Paul Douglas, Chidananda Swamy Rumalla, Muralidharan Kaliyaperumal. Novel LC–MS Method development and Validation for Characterization of Talazoparib, an Anti-cancer drug and its forced degradation behavior. Research Journal of Pharmacy and Technology. 2022; 15(6):2592-8. doi: 10.52711/0974-360X.2022.00433
Read More